184 related articles for article (PubMed ID: 23408929)
1. Curcumin potentiates rhabdomyosarcoma radiosensitivity by suppressing NF-κB activity.
Orr WS; Denbo JW; Saab KR; Ng CY; Wu J; Li K; Garner JM; Morton CL; Du Z; Pfeffer LM; Davidoff AM
PLoS One; 2013; 8(2):e51309. PubMed ID: 23408929
[TBL] [Abstract][Full Text] [Related]
2. Curcumin sensitizes human colorectal cancer xenografts in nude mice to gamma-radiation by targeting nuclear factor-kappaB-regulated gene products.
Kunnumakkara AB; Diagaradjane P; Guha S; Deorukhkar A; Shentu S; Aggarwal BB; Krishnan S
Clin Cancer Res; 2008 Apr; 14(7):2128-36. PubMed ID: 18381954
[TBL] [Abstract][Full Text] [Related]
3. Curcumin enhances the response of non-Hodgkin's lymphoma cells to ionizing radiation through further induction of cell cycle arrest at the G2/M phase and inhibition of mTOR phosphorylation.
Qiao Q; Jiang Y; Li G
Oncol Rep; 2013 Jan; 29(1):380-6. PubMed ID: 23117293
[TBL] [Abstract][Full Text] [Related]
4. Curcumin modulates the radiosensitivity of colorectal cancer cells by suppressing constitutive and inducible NF-kappaB activity.
Sandur SK; Deorukhkar A; Pandey MK; Pabón AM; Shentu S; Guha S; Aggarwal BB; Krishnan S
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):534-42. PubMed ID: 19735878
[TBL] [Abstract][Full Text] [Related]
5. Curcumin enhances the radiosensitivity of renal cancer cells by suppressing NF-κB signaling pathway.
Li G; Wang Z; Chong T; Yang J; Li H; Chen H
Biomed Pharmacother; 2017 Oct; 94():974-981. PubMed ID: 28810535
[TBL] [Abstract][Full Text] [Related]
6. IFN-beta restricts tumor growth and sensitizes alveolar rhabdomyosarcoma to ionizing radiation.
Sims TL; McGee M; Williams RF; Myers AL; Tracey L; Hamner JB; Ng C; Wu J; Gaber MW; McCarville B; Nathwani AC; Davidoff AM
Mol Cancer Ther; 2010 Mar; 9(3):761-71. PubMed ID: 20197402
[TBL] [Abstract][Full Text] [Related]
7. Curcumin improves the antitumor effect of X-ray irradiation by blocking the NF-κB pathway: an in-vitro study of lymphoma.
Qiao Q; Jiang Y; Li G
Anticancer Drugs; 2012 Jul; 23(6):597-605. PubMed ID: 22273827
[TBL] [Abstract][Full Text] [Related]
8. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
[TBL] [Abstract][Full Text] [Related]
9. Curcumin potentiates the antitumor effects of 5-FU in treatment of esophageal squamous carcinoma cells through downregulating the activation of NF-κB signaling pathway in vitro and in vivo.
Tian F; Fan T; Zhang Y; Jiang Y; Zhang X
Acta Biochim Biophys Sin (Shanghai); 2012 Oct; 44(10):847-55. PubMed ID: 23017833
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of radiosensitivity by proteasome inhibition: implications for a role of NF-kappaB.
Russo SM; Tepper JE; Baldwin AS; Liu R; Adams J; Elliott P; Cusack JC
Int J Radiat Oncol Biol Phys; 2001 May; 50(1):183-93. PubMed ID: 11316563
[TBL] [Abstract][Full Text] [Related]
11. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice.
Aggarwal BB; Shishodia S; Takada Y; Banerjee S; Newman RA; Bueso-Ramos CE; Price JE
Clin Cancer Res; 2005 Oct; 11(20):7490-8. PubMed ID: 16243823
[TBL] [Abstract][Full Text] [Related]
12. Curcumin potentiates laryngeal squamous carcinoma radiosensitivity via NF-ΚB inhibition by suppressing IKKγ expression.
Deng XZ; Geng SS; Luo M; Chai JJ; Xu Y; Chen CL; Qiu L; Ke Q; Duan QW; Song SM; Shen L; Luo ZG
J Recept Signal Transduct Res; 2020 Dec; 40(6):541-549. PubMed ID: 32515250
[No Abstract] [Full Text] [Related]
13. Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation.
Aggarwal S; Ichikawa H; Takada Y; Sandur SK; Shishodia S; Aggarwal BB
Mol Pharmacol; 2006 Jan; 69(1):195-206. PubMed ID: 16219905
[TBL] [Abstract][Full Text] [Related]
14. Curcumin synergistically enhances the radiosensitivity of human oral squamous cell carcinoma via suppression of radiation-induced NF-κB activity.
Chiang IT; Liu YC; Hsu FT; Chien YC; Kao CH; Lin WJ; Chung JG; Hwang JJ
Oncol Rep; 2014 Apr; 31(4):1729-37. PubMed ID: 24503718
[TBL] [Abstract][Full Text] [Related]
15. Cepharanthin-enhanced radiosensitivity through the inhibition of radiation-induced nuclear factor-kappaB activity in human oral squamous cell carcinoma cells.
Tamatani T; Azuma M; Motegi K; Takamaru N; Kawashima Y; Bando T
Int J Oncol; 2007 Oct; 31(4):761-8. PubMed ID: 17786306
[TBL] [Abstract][Full Text] [Related]
16. Curcumin reverses chemoresistance of human gastric cancer cells by downregulating the NF-κB transcription factor.
Yu LL; Wu JG; Dai N; Yu HG; Si JM
Oncol Rep; 2011 Nov; 26(5):1197-203. PubMed ID: 21811763
[TBL] [Abstract][Full Text] [Related]
17. Curcumin suppresses growth of head and neck squamous cell carcinoma.
LoTempio MM; Veena MS; Steele HL; Ramamurthy B; Ramalingam TS; Cohen AN; Chakrabarti R; Srivatsan ES; Wang MB
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6994-7002. PubMed ID: 16203793
[TBL] [Abstract][Full Text] [Related]
18. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB in breast cancer cells and potentiates the growth inhibitory effect of paclitaxel in a breast cancer nude mice model.
Kang HJ; Lee SH; Price JE; Kim LS
Breast J; 2009; 15(3):223-9. PubMed ID: 19645775
[TBL] [Abstract][Full Text] [Related]
19. The chemopreventive agent curcumin is a potent radiosensitizer of human cervical tumor cells via increased reactive oxygen species production and overactivation of the mitogen-activated protein kinase pathway.
Javvadi P; Segan AT; Tuttle SW; Koumenis C
Mol Pharmacol; 2008 May; 73(5):1491-501. PubMed ID: 18252805
[TBL] [Abstract][Full Text] [Related]
20. Curcumin sensitized the antitumour effects of irradiation in promoting apoptosis of oesophageal squamous-cell carcinoma through NF-κB signalling pathway.
Liu G; Wang Y; Li M
J Pharm Pharmacol; 2018 Oct; 70(10):1340-1348. PubMed ID: 30022485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]